gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Postoperative Complications

gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide has been researched along with Postoperative Complications in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ding, F; Duan, Z; Jiang, J; Li, J; Li, L; Li, Y; Liu, J; Liu, M; Song, Y; Wang, J; Xiao, Y; Zhai, X; Zhang, X; Zhu, L; Zhuang, H; Zou, H	1

Other Studies

1 other study(ies) available for gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Postoperative Complications

Article	Year
A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections. BMC infectious diseases, 2022, Nov-18, Volume: 22, Issue:1 Topics: Child; Child, Preschool; DNA, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infant; Postoperative Complications; Prospective Studies	2022

Article

Year

A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections.

BMC infectious diseases, 2022, Nov-18, Volume: 22, Issue:1

Topics: Child; Child, Preschool; DNA, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infant; Postoperative Complications; Prospective Studies

2022